Skip to Main Content
Our Commitment to Diversity

COVID-19: Historic Coronavirus Relief Package Enacted

Date: 27 March 2020
By: Brenden R. Chainey, Daniel S. Nuñez Cohen, Lauren M. Flynn, Brody Garland, Elle M. Stuart, Victoria K. Hamscho, Victoria Hamscho, Dean A. Brazier, Kathleen L. Nicholas, Eli M. Schooley

On Wednesday, March 25, a historic, bipartisan deal was reached in the Senate to offer $2 trillion in health care and economic relief to Americans and businesses amid the ongoing novel coronavirus (COVID-19) pandemic. The Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748) is a massive aid package containing a combination of funding for public health programs, tax benefits for businesses and individuals, appropriations for government programs supporting coronavirus relief efforts, and other items to help stabilize the economy.

Senators worked through the bill at breakneck speed, negotiating the final package in just four days. Those talks took place at the highest levels, with Senate Majority Leader Mitch McConnell (R-KY), Senate Minority Leader Chuck Schumer (D-NY), and House Speaker Nancy Pelosi (D-CA) sharing proposals between each other and Treasury Secretary Steven Mnuchin on behalf of the Trump administration. While some senators objected to certain aspects of the bill, such as the provisions covering unemployment benefits or corporate stabilization, the massive relief package passed by a remarkable 96-0 vote.

The House met on Friday, March 27, to consider the CARES Act. Remarkably, the chamber allowed the bill to pass by voice vote despite the $2 trillion price tag. A large number of members were unable to return to D.C. for a vote, either having themselves tested positive for COVID-19 or are in self-quarantine after coming into contact with someone who tested positive. That, coupled with the overwhelmingly bipartisan Senate vote and support from President Donald Trump, made the decision to decline a roll call vote necessary to get relief to individuals and businesses without further delay.
President Trump signed the bill into law (PL. 116-136) the same day.

The K&L Gates Public Policy & Law practice group has been assisting clients with provisions in the bill and monitoring related policy developments, and the firm’s lawyers and government relations professionals are working with clients on the implementation of government policies and legislation enacted to address the coronavirus pandemic. Should you have any questions regarding specific provisions in the bill, or other policies enacted by federal or state governments in response the pandemic, please email Darrell Conner, Karishma Page, Lauren Flynn, or Kathleen Nicholas.

Click here to read the full alert.

This publication/newsletter is for informational purposes and does not contain or convey legal advice. The information herein should not be used or relied upon in regard to any particular facts or circumstances without first consulting a lawyer. Any views expressed herein are those of the author(s) and not necessarily those of the law firm's clients.

Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel